000 | 01258 a2200337 4500 | ||
---|---|---|---|
005 | 20250516185907.0 | ||
264 | 0 | _c20140918 | |
008 | 201409s 0 0 eng d | ||
022 | _a1098-6596 | ||
024 | 7 |
_a10.1128/AAC.01651-13 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aAarnoutse, Rob | |
245 | 0 | 0 |
_aReply to "strategy to limit sampling of antituberculosis drugs instead of determining concentrations at two hours postingestion in relation to treatment response". _h[electronic resource] |
260 |
_bAntimicrobial agents and chemotherapy _c2014 |
||
300 |
_a629-30 p. _bdigital |
||
500 | _aPublication Type: Letter; Comment | ||
650 | 0 | 4 |
_aAntitubercular Agents _xpharmacokinetics |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aIsoniazid _xpharmacokinetics |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aPyrazinamide _xpharmacokinetics |
650 | 0 | 4 |
_aRifampin _xpharmacokinetics |
650 | 0 | 4 |
_aTuberculosis, Pulmonary _xdrug therapy |
700 | 1 | _aRuesen, Carolien | |
700 | 1 | _aBurhan, Erlina | |
700 | 1 | _avan Crevel, Reinout | |
700 | 1 | _aRuslami, Rovina | |
773 | 0 |
_tAntimicrobial agents and chemotherapy _gvol. 58 _gno. 1 _gp. 629-30 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1128/AAC.01651-13 _zAvailable from publisher's website |
999 |
_c23391074 _d23391074 |